These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37894777)

  • 1. Unravelling Novel
    Frosio A; Micaglio E; Polsinelli I; Calamaio S; Melgari D; Prevostini R; Ghiroldi A; Binda A; Carrera P; Villa M; Mastrocinque F; Presi S; Salerno R; Boccellino A; Anastasia L; Ciconte G; Ricagno S; Pappone C; Rivolta I
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.
    Maury P; Moreau A; Hidden-Lucet F; Leenhardt A; Fressart V; Berthet M; Denjoy I; Bennamar N; Rollin A; Cardin C; Guicheney P; Chahine M
    J Interv Card Electrophysiol; 2013 Aug; 37(2):131-40. PubMed ID: 23612926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
    Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
    Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
    Béziau DM; Barc J; O'Hara T; Le Gloan L; Amarouch MY; Solnon A; Pavin D; Lecointe S; Bouillet P; Gourraud JB; Guicheney P; Denjoy I; Redon R; Mabo P; le Marec H; Loussouarn G; Kyndt F; Schott JJ; Probst V; Baró I
    Basic Res Cardiol; 2014; 109(6):446. PubMed ID: 25341504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of Two Novel Mutations in
    Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomics trajectory and molecular convergence of clinically relevant mutations in Brugada syndrome.
    Tambi R; Abdel Hameid R; Bankapur A; Nassir N; Begum G; Alsheikh-Ali A; Uddin M; Berdiev BK
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1935-H1948. PubMed ID: 33797273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Analysis of SCN5A Genetic Variants Associated with Brugada Syndrome.
    Mikhailova VB; Karpushev AV; Vavilova VD; Klimenko ES; Tulintseva T; Yudina YS; Vasichkina ES; Zhorov BS; Kostareva A
    Cardiology; 2022; 147(1):35-46. PubMed ID: 34628415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
    Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
    Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel.
    Chen J; Li H; Guo S; Yang Z; Sun S; Zeng J; Gou H; Chen Y; Wang F; Lin Y; Huang K; Yue H; Ma Y; Lin Y
    Orphanet J Rare Dis; 2022 Oct; 17(1):394. PubMed ID: 36303204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
    Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
    Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations.
    Hsueh CH; Chen WP; Lin JL; Tsai CT; Liu YB; Juang JM; Tsao HM; Su MJ; Lai LP
    J Biomed Sci; 2009 Feb; 16(1):23. PubMed ID: 19272188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
    Wang QI; Ohno S; Ding WG; Fukuyama M; Miyamoto A; Itoh H; Makiyama T; Wu J; Bai J; Hasegawa K; Shinohara T; Takahashi N; Shimizu A; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 May; 25(5):522-530. PubMed ID: 24400717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SCN5A coding and non-coding sequences in Brugada syndrome onset: What's behind the scenes?
    Daimi H; Khelil AH; Neji A; Ben Hamda K; Maaoui S; Aranega A; Be Chibani J; Franco D
    Biomed J; 2019 Aug; 42(4):252-260. PubMed ID: 31627867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.